Vector Science Valuation Multiples
Vector Science is valued at $240M as of November 2026. In the last fiscal year, Vector Science EBITDA was ($898K).
Vector Science Overview
About Vector Science
Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
Founded
2021
HQ
Employees
N/A
Website
Financials (Last FY)
EV
$239M
Valuation Multiples
Start free trial
Vector Science Financials
Vector Science reported last fiscal year revenue of - and negative EBITDA of ($898K).
In the same fiscal year, Vector Science generated ($898K) in EBITDA losses and had net loss of ($898K).
Vector Science P&L
In the most recent fiscal year, Vector Science reported revenue of - and EBITDA of ($898K).
Vector Science is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Vector Science Stock Performance
Vector Science has current market cap of $240M, and enterprise value of $239M.
Market Cap Evolution
Vector Science's stock price is $1.54.
Vector Science share price increased by 9.0% in the last 30 days.
Vector Science has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $239M | $240M | -0.1% | 9.0% | - | - | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVector Science Valuation Multiples
Vector Science trades at (266.1x) EV/EBITDA.
Vector Science Financial Valuation Multiples
As of November 8, 2026, Vector Science has market cap of $240M and EV of $239M.
Vector Science has a P/E ratio of (267.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vector Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vector Science Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Vector Science competitors and their valuation data. Start Free Trial | ||||||
Investments by Vector Science
Vector Science has invested in 2 companies to date.
Latest investment by Vector Science was on October 13th 2026. Vector Science invested in Whoopi Wellness in their Strategic investment round.
Latest Investments by Vector Science
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Scoreboard | ||
| Description | Whoopi Wellness, Inc. is a consumer health and lifestyle brand associated with Whoopi Goldberg. The company presents itself as built on generations of care, wisdom and knowledge, and publishes investor information on its website. | Scoreboard, Inc. is a performance wellness company co-founded by NBA Hall of Famer Gary Payton. It is developing products for everyday athletes, high performers and weekend warriors, and plans peptide-based products for athletic performance, recovery and longevity in liquid and gel formats. In October 2026 Vector Science and Therapeutics Corp., a TSX Venture-listed medical technology company, invested in the business through a simple agreement for future equity. Vector's role is to formulate and manufacture the peptides, while Scoreboard contributes its brand and athlete network. |
| HQ Country |  | - |
| HQ City | Mequon | - |
| Deal Date | 13 Oct 2026 | 7 Oct 2026 |
| Round | Strategic investment | Strategic investment |
| Raised | undisclosed | undisclosed |
| Investors | Vector Science | Vector Science |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Vector Science investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vector Science
| When was Vector Science founded? | Vector Science was founded in 2021. |
| Where is Vector Science headquartered? | Vector Science is headquartered in Canada. |
| Who is the CEO of Vector Science? | Vector Science's CEO is William Jackson. |
| Is Vector Science publicly listed? | Yes, Vector Science is a public company listed on Toronto Stock Exchange. |
| What is the stock symbol of Vector Science? | Vector Science trades under PAIN ticker. |
| When did Vector Science go public? | Vector Science went public in 2026. |
| Who are competitors of Vector Science? | Vector Science main competitors include |
| What is the current market cap of Vector Science? | Vector Science's current market cap is $240M. |
| Is Vector Science profitable? | No, Vector Science is not profitable. |
| How many companies Vector Science has acquired to date? | Vector Science hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Vector Science has invested to date? | As of November 2026, Vector Science has invested in 2 companies. |
| What was the last Vector Science investment? | On 13th October 2026 Vector Science invested in Whoopi Wellness, participating in a Strategic investment round. |
| In what companies Vector Science invested in? | Vector Science invested in Scoreboard and Whoopi Wellness. |
Lists including Vector Science
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.